Skip to content
PubMed This is a summary of 76 peer-reviewed journal articles Updated
Nephrology

Secondary Hyperparathyroidism of Renal Origin: A Patient Guide

At a Glance

Renal secondary hyperparathyroidism occurs when declining kidney function disrupts phosphorus, calcium, and vitamin D balance, causing excess parathyroid hormone. Treatment is individualized and may include diet changes, medicines, monitoring, or surgery.

Secondary hyperparathyroidism (SHPT) of renal origin is a complex but manageable condition that arises when your kidneys can no longer maintain the delicate balance of minerals in your blood. As kidney function declines, the body struggles to process phosphorus and activate Vitamin D. This imbalance signals the four tiny parathyroid glands in your neck to become overactive. In an effort to keep your blood calcium levels stable, these glands produce excessive amounts of parathyroid hormone, which acts as a signal to pull calcium out of your bones and into your bloodstream [1].

This condition is a key component of a broader systemic issue known as Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Because the parathyroid glands are working so hard to balance your minerals, the rest of the body can experience unintended side effects. Over time, the constant removal of calcium can contribute to bone fragility and an increased risk of fractures. Furthermore, when minerals like calcium and phosphorus are out of balance in the blood, they can begin to deposit in soft tissues and blood vessels. This process, along with other factors like age and diabetes, can contribute to the “hardening” of arteries and affect your overall cardiovascular health [2].

An Individualized Approach to Care

It is important to remember that CKD-MBD varies widely from person to person. A treatment target or medication that works for someone on dialysis might not be appropriate for someone in earlier stages of kidney disease. Your lab targets and treatment plan will be highly individualized based on your kidney function, transplant status, and the specific guidelines your nephrology team follows.

Managing SHPT is a long-term process that focuses on stabilizing these mineral levels before they cause lasting damage. Care typically begins with a focus on your diet, specifically by limiting the intake of phosphorus additives with the help of a renal dietitian. As the condition progresses, your medical team may introduce various medications—such as phosphate binders, Vitamin D supplements, or specialized drugs called calcimimetics—to help regulate your hormones and minerals. In some advanced cases where medications are no longer effective, a surgical procedure to remove part or all of the parathyroid glands may be considered [3].

While the biology behind SHPT is intricate, the goal of treatment is straightforward: to protect your bones, your heart, and your overall well-being. By staying engaged with your lab monitoring and working closely with your nephrology team, you can take proactive steps to manage these changes. Understanding how your kidneys and parathyroid glands interact allows you to become an active partner in your care, ensuring that your treatment plan is tailored to your unique needs and long-term health goals [4].

Common questions in this guide

What causes renal secondary hyperparathyroidism?
As kidney function declines, the kidneys have more difficulty handling phosphorus and activating vitamin D. This mineral imbalance signals the parathyroid glands to release too much parathyroid hormone in an effort to keep blood calcium stable.
What problems can renal secondary hyperparathyroidism cause?
Excess parathyroid hormone can pull calcium from bones, making them fragile and increasing fracture risk. Imbalances in calcium and phosphorus can also cause mineral deposits in soft tissues and blood vessels, which may affect cardiovascular health.
Which lab results matter most for tracking this condition?
Your care team may follow trends in parathyroid hormone, calcium, and phosphorus, along with other results based on your kidney condition. There is no single target for everyone because interpretation depends on kidney function, dialysis or transplant status, and the guidelines your nephrology team uses.
What treatments are used for renal secondary hyperparathyroidism?
Management may include limiting phosphorus additives with help from a renal dietitian, plus phosphate binders, vitamin D supplements, or calcimimetics that help regulate hormone and mineral levels. If medicines are no longer effective, surgery to remove part or all of the parathyroid glands may be considered.
Does everyone with kidney disease need the same treatment for this condition?
No. Treatment targets and medication choices vary with kidney function, dialysis or transplant status, laboratory trends, and the guidelines followed by the nephrology team. Your plan should be individualized rather than copied from another patient.
What happens if my parathyroid hormone level keeps rising?
Your care team can review your laboratory trends, diet, kidney function, and current medicines to decide what should change. Depending on the overall picture, they may adjust treatment or discuss parathyroid surgery if medicines no longer control the condition.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How would you describe the current stage of my mineral and bone health?
  2. 2.Which lab results should I pay the most attention to when looking at my own trends?
  3. 3.How does my kidney function specifically affect the way my parathyroid glands are behaving right now?
  4. 4.What are the first steps we will take if my parathyroid hormone levels continue to rise?
  5. 5.How can I best coordinate my care between my kidney specialist and other members of my medical team?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (4)
  1. 1

    Current and Emerging Markers and Tools Used in the Diagnosis and Management of Chronic Kidney Disease-Mineral and Bone Disorder in Non-Dialysis Adult Patients.

    Fusaro M, Pereira L, Bover J

    Journal of clinical medicine 2023; (12(19)) doi:10.3390/jcm12196306.

    PMID: 37834950
  2. 2

    Current Understanding of Mineral and Bone Disorders of Chronic Kidney Disease and the Scientific Grounds on the Use of Exogenous Parathyroid Hormone in Its Management.

    Pazianas M, Miller PD

    Journal of bone metabolism 2020; (27(1)):1-13 doi:10.11005/jbm.2020.27.1.1.

    PMID: 32190604
  3. 3

    Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update.

    Ketteler M, Block GA, Evenepoel P, et al.

    Annals of internal medicine 2018; (168(6)):422-430 doi:10.7326/M17-2640.

    PMID: 29459980
  4. 4

    Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD): Current Perspectives.

    Waziri B, Duarte R, Naicker S

    International journal of nephrology and renovascular disease 2019; (12()):263-276 doi:10.2147/IJNRD.S191156.

    PMID: 31920363

This page is for informational purposes only and does not constitute medical advice. Your nephrology team should interpret your laboratory results and tailor diet, medicines, monitoring, or surgery to your kidney function and overall health.

Get notified when new evidence is published on secondary hyperparathyroidism of renal origin.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.